Zymeworks (ZYME) Interest & Investment Income (2023 - 2026)
Zymeworks (ZYME) reported Interest & Investment Income of -$486000.0 for Q1 2026, down 189.01% on a YoY basis from $546000.0 in Q1 2025, and down 1575.86% sequentially from -$29000.0 in Q4 2025.
Zymeworks (ZYME) Interest & Investment Income (2023 - 2026) Analysis & Trends
Zymeworks (ZYME) has 4 years of Interest & Investment Income data on file, last reported at -$486000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 189.01% year-over-year to -$486000.0; the trailing twelve-month figure through Mar 2026 stood at -$159000.0 (down 112.06% YoY), and the FY2025 full-year result was $873000.0, up 350.14% from the prior year.
- Interest & Investment Income fell to -$486000.0 in Q1 2026, from -$29000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.9 million in Q3 2024 to a low of -$1.9 million in Q2 2023.
- A 4-year average of $7230.8 and a median of -$29000.0 in 2025 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 492.78% in 2024, while the deepest fall reached 255.69% in 2024.
- Tracing ZYME's Interest & Investment Income over 4 years: stood at $1.7 million in 2023, then plunged by 156.22% to -$953000.0 in 2024, then surged by 96.96% to -$29000.0 in 2025, then slumped by 1575.86% to -$486000.0 in 2026.
- Business Quant data shows ZYME's Interest & Investment Income at -$486000.0 in Q1 2026, -$29000.0 in Q4 2025, and $290000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | -486,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -486,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | 546,000.00 |
| Dec 31, 2024 | -953,000.00 |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -1.12 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | -485,000.00 |
| Jun 30, 2023 | -1.87 Mn |
| Mar 31, 2023 | 720,000.00 |